http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2365172

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 3502
issn 0732-183X
1527-7755
issueIdentifier 23
pageRange 3495-3502
publicationName Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage 3495
bibliographicCitation Engert A, Franklin J, Eich HT, Brillant C, Sehlen S, Cartoni C, Herrmann R, Pfreundschuh M, Sieber M, Tesch H, Franke A, Koch P, de Wit M, Paulus U, Hasenclever D, Loeffler M, Müller RP, Müller-Hermelink HK, Dühmke E, Diehl V. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial. J Clin Oncol. 2007 Aug 10;25(23):3495–502. doi: 10.1200/jco.2006.07.0482. PMID: 17606976.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66ed18412c7f52c05b6583b5fde99649
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30b86001086ea96178f682b34ec2038d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac4abca8e7da072d2776aa97d2e77d44
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4724bcf07d49cd3a80c65d3805c9f8bc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dacf3ddbd8b8feb5395736eca77729eb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3796905e3191a30b00cda7cbdd71d7e1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d0918be2d39bbc3d25da2ab3ff351f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc5dc4fcd6223473f4f7f8a83829c148
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8c0422aab2f4bc0f8e1ffe6031b0b57
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4abbb2862a2cbde8e3de1c59c9c9aa0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fbbf616acea287aedb219dab4523bfd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a21b105c3c0529e346ee23d5d4abb2da
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6529bed201da9a77a6ae3de409bd0377
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e49f4e6069f90dd95ceced6e2fd1fec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2dbb1ff7a89fac907cb5bae4bac9c76f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_534b1b2847cd1f94acbd63fe7706424e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3df994fe484c64992b010e2878def3af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f445d2162dd1052298e8ef2355b2039
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f74a0cbf0777e64ca9e18f83ee23a77
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e9ab0da0a1cb7ad207b682675718d07
date 2007-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/17606976
https://doi.org/10.1200/jco.2006.07.0482
isPartOf https://portal.issn.org/resource/ISSN/1527-7755
https://portal.issn.org/resource/ISSN/0732-183X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkin's Lymphoma: Final Results of the GHSG HD7 Trial
discusses http://id.nlm.nih.gov/mesh/M0022672
http://id.nlm.nih.gov/mesh/M0005636
http://id.nlm.nih.gov/mesh/M0002657
http://id.nlm.nih.gov/mesh/M0006784
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D006689Q000188
http://id.nlm.nih.gov/mesh/D006689Q000532
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D001761Q000627
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D004317Q000627
http://id.nlm.nih.gov/mesh/D018787Q000379
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D003131
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D014747Q000627
http://id.nlm.nih.gov/mesh/D003606Q000627
http://id.nlm.nih.gov/mesh/D013997
http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129009934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133126830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44417235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155903698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6710780
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_daa31e5601dc8e8d613ec227a938992f
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3823887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11104792
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135659048
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84068

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127830723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787668

Total number of triples: 106.